Aclaris Therapeutics, Inc. (LSE) · Health Technology. hisse senedi canlı fiyat verisi ve teknik analiz görünümü. LSE (Londra Borsası) verilerini Alerta Chart üzerinden takip edin.
Veri erişimi kontrol ediliyor...
Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through the Therapeutics and Contract Research segments. The Therapeutics segment focuses on identifying, developing, and commercializing different therapies to address significant unmet needs in medical and aesthetic dermatology. The Contract Research segment provides laboratory services under contract research arrangements to pharmaceutical and biotech companies. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala, and Stuart D. Shanler in July 2012 and is headquartered in Wayne, PA.
Alerta Chart Pro Terminal ile aynı anda 4 grafiği takip edebilir, derinlik (order book) verilerini görebilir ve 25 aktif alarm kurabilirsiniz.
Ücretsiz Başla